Latest filing published 17 Jun 2025 for Anaptysbio, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Rita Jain across 2 companies, led by ChemoCentryx, Inc. and Anaptysbio, Inc. The record holds 6 filings, for trades running from 21 May 2021 to 15 June 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 17 June 2025 with an option exercise in Anaptysbio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations